Aspiriant LLC’s Cardinal Health CAH Stock Holding History

Aspiriant LLC’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,648	Closed	-$204K	–	280
2022 Q4	$204K	Buy	+2,648	New	+$201K	0.01%	263
2018 Q2	–	Sell	-3,524	Closed	-$221K	–	247
2018 Q1	$221K	Buy	+3,524	New	+$242K	0.02%	225
2017 Q4	–	Sell	-4,223	Closed	-$283K	–	98
2017 Q3	$283K	Hold	4,223	–	–	0.02%	168
2017 Q2	$329K	Sell	4,223 -1,466	-26%	-$111K	0.03%	166
2017 Q1	$464K	Buy	5,689 +391	+7%	+$30.8K	0.04%	153
2016 Q4	$381K	Sell	5,298 -63	-1%	-$4.55K	0.03%	150
2016 Q3	$417K	Sell	5,361 -103	-2%	-$8.32K	0.04%	147
2016 Q2	$426K	Buy	5,464 +166	+3%	+$13.2K	0.04%	144
2016 Q1	$434K	Hold	5,298	–	–	0.04%	139
2015 Q4	$473K	Hold	5,298	–	–	0.05%	59
2015 Q3	$407K	Hold	5,298	–	–	0.03%	74
2015 Q2	$443K	Hold	5,298	–	–	0.04%	79
2015 Q1	$478K	Hold	5,298	–	–	0.06%	62
2014 Q4	$428K	Buy	+5,298	New	+$418K	0.06%	63

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Aspiriant LLC's CAH Position: Q1 2023 in Review

Aspiriant LLC sold out of Cardinal Health (CAH) in Q1 2023, closing a stake of 2,648 shares — an estimated $204K sold.

Aspiriant LLC first reported a position in CAH in Q4 2014 and held it in 14 quarters. The position peaked at $478K in Q1 2015. 906 funds tracked by Wall St. Rank hold CAH as of Q1 2023.

Aspiriant LLC reported no remaining Cardinal Health position as of Q1 2023 after selling out during the quarter.
Aspiriant LLC sold 2,648 Cardinal Health shares in Q1 2023, an estimated $204K.
Aspiriant LLC first reported a position in Cardinal Health in Q4 2014 and held it in 14 quarters.
Aspiriant LLC's Cardinal Health position peaked at $478K in Q1 2015.
906 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2023.

Based on Aspiriant LLC's 13F filing for Q1 2023, filed 27 Apr 2023.